Oxaliplatin
NDC 61703-363, OXALIPLATIN, injection, solution, concentrate, from Hospira, Inc..
- Product NDC
- 61703-363
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078813
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61703-363 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXALIPLATIN5 mg/mL
Pharmacologic classes
Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61703-363-18 | 61703036318 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-18) / 10 mL in 1 VIAL, SINGLE-DOSE |
| 61703-363-22 | 61703036322 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-22) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e51a62ba-d163-4c57-835c-8c86cf097e40Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61703-363
Use it
Look up 61703-363 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61703-363 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61703-363. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.